Skip to content

In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists.

Françis C. Colpaert, C J Niemegeers, P A Janssen

European Journal of Pharmacology October 15, 1979 DOI: 10.1016/0014-2999(79)90326-1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Animal behavioral pharmacology experiment (drug discrimination) Peer reviewed
Sample size 9
Population Rats trained in a food-reinforced two-lever operant drug-discrimination task
Interventions LSD cyproheptadine methysergide mianserin mescaline quipazine
Dose LSD 0.16 mg/kg; cyproheptadine 1.25 and 10 mg/kg; methysergide 0.16 to 10 mg/kg; mianserin 2.5 to 40 mg/kg; mescaline 5 to 40 mg/kg; quipazine 1.25 to 5 mg/kg
Key findings Rats trained to discriminate 0.16 mg/kg LSD from saline showed partial generalization to the purported 5-HT antagonists cyproheptadine, methysergide and mianserin, and full generalization to the hallucinogens mescaline and quipazine. The authors suggest the three antagonists may exert partial agonist effects at central 5-HT receptors in addition to their antagonist action.

Abstract

Using a food-reinforced two-lever operant method, rats (n = 9) were trained to discriminate 0.16 mg/kg LSD from saline. Tests for stimulus generalization in rats so trained indicated that the purported 5-HT antagonists cyproheptadine (1.25 and 10 mg/kg), methysergide (0.16 to 10 mg/kg) and mianserin (2.5 to 40 mg/kg) produced partial generalization with LSD. The hallucinogens mescaline (5 to 40 mg/kg) and quipazine (1.25 to 5 mg/kg) were also generalized with LSD. The data suggest that cyproheptadine, methysergide and mianserin may produce partial agonist effects in addition to their antagonist action at central 5-HT receptor sites.

Citations in the library

Explore topics